Fred Alger Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Fred Alger Management's JAZZ Position: Q2 2026 in Review
Fred Alger Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 1,182 shares — an estimated $223K sold.
Fred Alger Management first reported a position in JAZZ in Q1 2014 and held it in 20 quarters. The position peaked at $24.3M in Q3 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Fred Alger Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Fred Alger Management sold 1,182 Jazz Pharmaceuticals shares in Q2 2026, an estimated $223K.
- Fred Alger Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and held it in 20 quarters.
- Fred Alger Management's Jazz Pharmaceuticals position peaked at $24.3M in Q3 2014.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.